Earlier studies proposed an array of genetic factors and genetic aberrations leading to the development of NPC, including NF-κB pathway activating mutations, chromatin modification-related mutations, ERBB-PI3K signaling activating mutations, etc.5,8–11. This evidence concerns the gene EGFR and nasopharyngeal carcinoma.